4-Iod-N-phenylanthranilsaeure | 19218-87-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Iod-N-phenylanthranilsaeure
• 英文别名: 2-Anilino-4-iodobenzoic acid
• CAS: 19218-87-2
• 化学式: C₁₃H₁₀INO₂
• 分子量: 339.132
• InChiKey: FMXNZADDTHWQRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
  申请人：——

  公开号：US20030232889A1

  公开（公告）日：2003-12-18

  The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions, and methods of use thereof.

  本发明涉及氧化酯化的4-取代苯胺基苯基羟肟酸衍生物、药物组合物及其使用方法。
• Combination chemotherapy
  申请人：——

  公开号：US20040171632A1

  公开（公告）日：2004-09-02

  Mitotic inhibitors such as paclitaxel have improved antitumor activity when used in combination with a selective MEK inhibitor, especially a phenyl amine compound of Formula I and II: 1

  有丝分裂抑制剂如紫杉醇在与选择性MEK抑制剂结合使用时，特别是Formula I和II的苯胺化合物，已提高抗肿瘤活性。
• Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
  申请人：Vankayalapati Hariprasad

  公开号：US20100222381A1

  公开（公告）日：2010-09-02

  Compounds represented by Formula (I): are useful in treating diseases, such as cancer, that are mediated and/or associated (at least in part) with DNMT3b activity. The compounds can be formulated as pharmaceutically acceptable compositions for administration to a subject in need thereof.

  由式（I）表示的化合物在治疗疾病方面很有用，例如癌症，这些疾病与DNMT3b活性有关。这些化合物可以制备成药学上可接受的组合物，用于向需要的受试者施用。
• N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
  申请人：Rewcastle William Gordon

  公开号：US20050137263A1

  公开（公告）日：2005-06-23

  The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.

  本发明涉及4-取代苯胺苯羟基甲酸衍生物的氧化酯、制药组合物及其使用方法。
• 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
  申请人：——

  公开号：US20020022647A1

  公开（公告）日：2002-02-21

  Phenylamino benzoic acid, benzamides, and benzyl alcohol derivatives of the formula 1 where R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are hydrogen or substituent groups such as alkyl, and where R 7 is hydrogen or an organic radical, and Z is COOR 7 , tetrazolyl, CONR 6 R 7 , or CH 2 OR 7 , are potent inhibitors of MEK and, as such, are effective in treating cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders.

  苯基氨基苯甲酸，苯甲酰胺和苄醇衍生物的公式1，其中R1、R2、R3、R4、R5和R6为氢或取代基团，如烷基，其中R7为氢或有机基团，Z为COOR7、四唑基、CONR6R7或CH2OR7，是MEK的有效抑制剂，因此可用于治疗癌症和其他增殖性疾病，如炎症、银屑病和再狭窄，以及中风、心力衰竭和免疫缺陷病。